§ Funding Round
Angitia Biopharmaceuticals Series D
Angitia Biopharmaceuticals Series D
| Investor | Firm Type | Partner |
|---|---|---|
Frazier Life SciencesLEAD | — | — |
VenrockLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
BVF Partners | — | — |
Elikon Venture | — | — |
| Organization | — | |
Janus Henderson Investors | — | — |
| Organization | — | |
Logos Capital | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$336M
Top Valuation
-
Angitia Biopharmaceuticals raised $130M in a Series D round.
The round was announced on 02/05/26.
The round was led by Frazier Life Sciences, Venrock.
